Background: Non-Hodgkin lymphoma (NHL) is the most common cancer among people living with HIV in the United States. People with HIV are up to 17 times more li…

Diffuse Large Cell LymphomaNon-Hodgkin LymphomaBurkitt Lymphoma+2 more

~Estimated

~$10 – $5,625

National Cancer Institute (NCI)NCT05389423

Phase 1

A Phase 1, Open-Label, Multicenter, Dose Escalation Study of SGR-1505 as Monotherapy in Subjects With Mature B-Cell Malignancies

The purpose of this study is to evaluate safety and tolerability and to determine the maximum tolerated dose (MTD) or maximum administered dose (MAD) and/or re…

Mature B-Cell NeoplasmNon Hodgkin LymphomaDLBCL+23 more

~Estimated

~$10 – $8,750

Schrödinger, Inc.

NCT05544019